The Eyes Have It: AI-Powered Gaze Tracking for Early Alzheimer’s Risk Detection
Description
SeniorLife.AI detects amnestic mild cognitive impairment (aMCI)—a precursor to Alzheimer’s—up to 10 years before clinical diagnosis
How might life be different if early signs of Alzheimer’s could be detected a decade earlier—and preventative measures taken in time?
In this episode of #TheSeniorSpotlight, host Mary Cordova welcomes back Ash Roy and Shoko Hoshi, the visionary minds behind SeniorLife.AI, to unveil a groundbreaking advancement in early Alzheimer’s risk detection.
Learn how a simple, 5-minute eye-tracking test—conducted on an iPad—can identify amnestic mild cognitive impairment (aMCI), a potential early warning sign of Alzheimer’s, up to ten years before traditional diagnosis.
Ash and Shoko explain the powerful science behind gaze tracking, how their AI is trained on real patient data, and why early identification of aMCI opens the door to life-changing interventions. Best of all, this technology is designed to be accessible, affordable, and easy to use in real-world settings—from senior living communities to home care or primary care clinics.
Concierge Care Advisors is proud to be the exclusive distributor of SeniorLife.AI in the United States.
To learn more or request a demo, visit https://conciergecareadvisors.com/ai-powered-senior-care/.
United States
